Novo Nordisk shares fell 2.6% in premarket trading. Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, as it set the most pessimistic target price forecast of any Wall Street bank on the Danish drugmaker.

BHP shares fell 2% in premarket trading. China’s state-run iron ore buyer, China Mineral Resources Group Co. (CMRG), has instructed major steelmakers and traders to temporarily halt purchases of all new BHP Group cargoes, expanding an earlier curb as contract talks stalled, according to people familiar with the matter.

EchoStar shares rose 7% in premarket trading. U.S. telecom company Verizon is in discussions with EchoStar about purchasing some of its wireless spectrum, Bloomberg News reported on Monday, citing people familiar with the matter.

The discussions involve the satellite communications firm's AWS-3 licenses, valuable for carrying 5G wireless signals, the report said.

If the deal goes through, Verizon would join AT&T and SpaceX as buyers of EchoStar's wireless spectrum licenses, according to Bloomberg.

Earlier this month, EchoStar said it expects to hold $24.1 billion in cash after using spectrum sale proceeds to repay debt, further strengthening its balance sheet and supporting growth across wireless, satellite and tech.

Firefly Aerospace shares plunged 11% in premarket trading after the company disclosed an incident during a test at its facility in Briggs, Texas, that resulted in the loss of a rocket stage.

Energy Fuels announced plans to offer $550 million in convertible senior notes due 2031 through a private placement to qualified institutional buyers. The uranium and rare earth elements producer also intends to grant initial purchasers an option to buy up to an additional $82.5 million in notes within 13 days of issuance. The shares sank 7% in premarket trading.